Director, Corporate National Accounts
Description:
The Director, Corporate National Accounts (CNA) will serve as the primary relationship owner and strategic lead for a portfolio of national commercial payers, PBMs, and critical downstream accounts. This individual will be responsible for developing and executing payer account strategies that support favorable formulary positioning, reimbursement, and coverage policy for Viaskin® Peanut. The CNA will work cross-functionally with HEOR, medical affairs, contracting, and patient access teams to deliver a compelling value story to payer decision-makers.
This role requires a seasoned market access professional who is comfortable navigating complex clinical and policy conversations, building executive-level payer relationships, and operating in a fast-moving, pre-commercial environment.
Location: Remote
Salary Range: 240-270k
Key Responsibilities:
Account Strategy & Execution
Serve as lead for DBV relationship and B2B engagement with assigned accounts
Identify competitive threats and develop response strategies to ensure optimal access for products
Develop and own account-level plans for assigned national or regional payers, inclusive of formulary strategy, coverage policy objectives, and contracting priorities
Establish and maintain executive-level relationships with medical directors, pharmacy directors, and formulary committee decision-makers
Lead payer negotiations and contracting discussions in partnership with the Market Access contracting team, ensuring alignment with overall pricing strategy
Value Communication
Communicate the clinical, economic, and humanistic value of Viaskin® Peanut to payer audiences, translating HEOR data and real-world evidence into decision-relevant insights
Effectively articulate the differentiated profile of EPIT as a novel, non-invasive immunotherapy in a competitive and evolving food allergy treatment landscape
Develop and deliver tailored account-specific value dossiers and budget impact models in collaboration with HEOR and medical affairs
Pre-Launch & Launch Readiness
Anticipate and proactively address payer policy questions and potential coverage barriers prior to launch
Partner with patient services and hub operations to ensure reimbursement pathways are operationally aligned with payer coverage decisions
Contribute to the development of payer-facing materials and market access tools in partnership with marketing and regulatory
Establish KPIs to monitor progress and area of opportunity
Cross-Functional Collaboration
Works closely with Regional Account Manager(s) and sales leadership to drive field force communications on relevant reimbursement issues and pull through maximization
Serve as the voice of the payer internally, providing competitive intelligence, formulary landscape updates, and account-specific feedback to inform brand strategy
Partner closely with field outcomes teams to ensure coordinated account engagement
Represent market access in account-level business reviews and brand team planning cycles
Qualifications:
Education
Bachelor’s Degree required; Advanced Degree preferred
Experience
A minimum of 10+ years of biotech/pharma of Market Access experience with prior leadership roles in account management and/or sales management
Must complete all required safety and certification training and must maintain an acceptable driving record regarding accidents and incidents
Requires greater than 50% travel
Experience integrating Health Economics and Medical Affairs resources into access planning
Demonstrated ability to collaborate with a diverse matrix of internal stakeholders (e.g., Market Access Account team, field sales, brand marketing, Medical, legal, compliance, Trade, Patient Services, Data & Analytics) to achieve access goals
Ability to identify future policies, practices and trends that will affect payer management and access decision making in the marketplace
Experience leading pull through efforts with sales leadership and field sales teams
Knowledge
Strong Market Access Payer and PBM (Commercial, and Managed Medicaid) understanding
Well-developed negotiation skills
A high level of awareness and understanding of the implications and opportunities of contract strategy
Experience identifying trends and insights and assimilating to development of a broader strategy
Maintain accurate account profiles and customer interactions via CRM.
Technical Skills
An in-depth knowledge of key account selling for targeted channels/segments.
Previous experience in both specialty outpatient at the national account level
Experience in contract development and negotiation with exceptional consultative and networking capabilities
Experienced in customer negotiation, financial analysis, legal influences, and execution/ implementation of contracting activities
Leadership & Behavioral Skills
Demonstrated ability to influence the broader organization; motivates others with a positive attitude, leading through adversity and change
The ability to influence key decision makers in targeted account segments
Strong executive presence, communication and presentation skills with proven ability to operate and influence cross-functionally and with senior management
Strong financial acumen, analytical skills, and critical thinking ability
Proven ability to simultaneously manage numerous priorities, products, projects, etc
Demonstrates excellent organization and time management skills
Comfort operating in an ambiguous, fast paced, pre-commercial environment
Curiosity – demonstrated desire to learn, explore, and understand new things.
Courage – ability to confront fear, uncertainty, and challenges with confidence and resolve.
Collaboration -working with others to achieve a common goal.
Credibility – builds trust, is reliable, acts with ethics and integrity.
- Department
- Sales & Marketing
- Locations
- US - Warren, NJ
- Remote status
- Fully Remote
- Employment type
- Full-time
About DBV Technologies
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.
We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™, to develop treatment options for immunologic diseases with significant unmet medical need.
This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin.
Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy.
Tomorrow, as pioneers, we will continue to explore the broad applications of this potential new class of immunotherapy, including treatments for patients suffering from inflammatory and autoimmune diseases.